- Home
- MVBF vs INBX Comparison
MVBF vs INBX Comparison
Compare MVBF & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVBF
- INBX
- Stock Information
- Founded
- MVBF 1997
- INBX 2010
- Country
- MVBF United States
- INBX United States
- Employees
- MVBF N/A
- INBX N/A
- Industry
- MVBF Major Banks
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- MVBF Finance
- INBX Health Care
- Exchange
- MVBF Nasdaq
- INBX Nasdaq
- Market Cap
- MVBF 278.3M
- INBX 178.5M
- IPO Year
- MVBF N/A
- INBX 2020
- Fundamental
- Price
- MVBF $23.22
- INBX $21.73
- Analyst Decision
- MVBF Buy
- INBX Hold
- Analyst Count
- MVBF 4
- INBX 1
- Target Price
- MVBF $24.75
- INBX N/A
- AVG Volume (30 Days)
- MVBF 45.9K
- INBX 120.3K
- Earning Date
- MVBF 07-28-2025
- INBX 08-12-2025
- Dividend Yield
- MVBF 2.88%
- INBX N/A
- EPS Growth
- MVBF N/A
- INBX N/A
- EPS
- MVBF 1.46
- INBX 111.58
- Revenue
- MVBF $146,101,000.00
- INBX $200,000.00
- Revenue This Year
- MVBF N/A
- INBX N/A
- Revenue Next Year
- MVBF $14.22
- INBX N/A
- P/E Ratio
- MVBF $16.15
- INBX $0.20
- Revenue Growth
- MVBF N/A
- INBX N/A
- 52 Week Low
- MVBF $15.59
- INBX $10.80
- 52 Week High
- MVBF $25.24
- INBX $22.28
- Technical
- Relative Strength Index (RSI)
- MVBF 79.48
- INBX 84.22
- Support Level
- MVBF $22.85
- INBX $13.97
- Resistance Level
- MVBF $23.63
- INBX $15.25
- Average True Range (ATR)
- MVBF 0.50
- INBX 1.10
- MACD
- MVBF 0.13
- INBX 0.66
- Stochastic Oscillator
- MVBF 95.93
- INBX 95.32
About MVBF MVB Financial Corp.
MVB Financial Corp is a bank holding company. The company provides Personal banking, Business banking, and Fintech solutions. The group has identified three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of ts revenue generated from the CoRe Banking segment, which includes the Fintech division, represents banking products and services offered to customers by the Bank, loans, and deposit accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.